JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A8351 VX-809

Target: CFTR

Summary: CFTR corrector

≥22.6 mg/mL
A8435 Furosemide

Target: Na /K /Cl- Symporters (NKCCs)|GABAA Receptors

Summary: GABAA receptors antagonist
A8438 Glipizide

Summary: Oral anti-diabetic medication

insoluble in H2O; ≥16.8 mg/mL
A8439 GSK1292263

Summary: Novel GPR119 agonist

≥21.1 mg/mL
A8447 Imidapril HCl

Target: ACE

Summary: RAAS inhibitor

insoluble in H2O; ≥16.5 mg/mL
A8477 MK-8776 (SCH-900776)

Target: Chk

Summary: Chk1 inhibitor,potent and selective

insoluble in H2O; insoluble in EtOH; ≥18.8 mg/mL
A8539 Tretinoin (Aberela)

Target: RAR/RXR

Summary: retinoic acid, treats acne vulgaris and keratosis pilaris

insoluble in H2O; ≥11.9 mg/mL
A8398 Chlorprothixene

Summary: Dopamine receptor antagonist

insoluble in H2O; ≥13.43 mg/mL
A8410 Didanosine

Target: Reverse Transcriptases

Summary: Reverse transcriptase inhibitor

insoluble in H2O; insoluble in EtOH; ≥23.61 mg/mL
A8557 TAE226 (NVP-TAE226)
1 Citation

Target: FAK

Summary: FAK inhibitor,potent and ATP-competitive

≥23.45 mg/mL